Publisher: GlobalData
Category: Pharmaceuticals

Pharmaceuticals market research reports by GlobalData

(1,845 reports matching your criteria)
    • Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome) - Global Clinical Trials Review, 2024

      Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome) - Global Clinical Trials Review, 2024 Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Interstitial Cystitis (Painful Bladde ... Read More

    • Hypoglycemia - Global Clinical Trials Review, 2024

      Hypoglycemia - Global Clinical Trials Review, 2024 Hypoglycemia - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Hypoglycemia - Global Clinical Trials Review, 2024"" provides an overview of Hypoglycemia Clinical trials scenario. This report provides top line data re ... Read More

    • Osteoporosis: Seven-Market Drug Forecast and Market Analysis

      Osteoporosis: Seven-Market Drug Forecast and Market Analysis Summary This report covers the 7MM (US, France, Germany, Italy, Spain, UK, Japan) and provides an Excel-based forecast model for the Osteoporosis market through 2033. Osteoporosis is defined as a systemic skeletal disease characterized by ... Read More

    • Chronic Kidney Disease: Seven-Market Drug Forecast and Market Analysis

      Chronic Kidney Disease: Seven-Market Drug Forecast and Market Analysis Summary This report covers the 7MM (US, France, Germany, Italy, Spain, UK, Japan) and provides an Excel-based forecast model for the Chronic Kidney Disease (CKD) market through 2033. GlobalData estimates the sales of CKD therapeu ... Read More

    • Chronic Kidney Disease: Epidemiology Forecast to 2033

      Chronic Kidney Disease: Epidemiology Forecast to 2033 Summary Chronic kidney disease (CKD), or chronic renal disease (International Classification of Diseases 10th Revision [ICD-10] code = N18), is a condition characterized by a gradual loss of kidney function over time. This leads to the accumulati ... Read More

    • Niemann Pick Type C: Opportunity Assessment and Forecast - Update

      Niemann Pick Type C: Opportunity Assessment and Forecast - Update Summary The prevalence of Niemann Pick Type C (NPC) is increasing at a steady rate, in line with population growth in the 3MM at an AGR of 0.29%. Currently, the treatment regimen for NPC in the 3MM is entirely limited to the use of mi ... Read More

    • Spinal Cord Stimulators (SCS) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

      Spinal Cord Stimulators (SCS) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Spinal Cord Stimulators (SCS) Pipeline Report including Stages of Development, Segments, ... Read More

    • Renal Denervation Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

      Renal Denervation Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Renal Denervation Catheters Pipeline Report including Stages of Development, Segments, Regi ... Read More

    • Madrigal Pharmaceuticals Inc (MDGL) - Financial and Strategic SWOT Analysis Review

      Madrigal Pharmaceuticals Inc (MDGL) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an ... Read More

    • Karyopharm Therapeutics Inc (KPTI) - Financial and Strategic SWOT Analysis Review

      Karyopharm Therapeutics Inc (KPTI) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and ... Read More

    • Revance Therapeutics Inc (RVNC) - Financial and Strategic SWOT Analysis Review

      Revance Therapeutics Inc (RVNC) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we ... Read More

    • Ipsen SA (IPN) - Financial and Strategic SWOT Analysis Review

      Ipsen SA (IPN) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the ... Read More

    • Lonza Group Ltd (LONN) - Financial and Strategic SWOT Analysis Review

      Lonza Group Ltd (LONN) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses ... Read More

    • Owens & Minor Inc (OMI) - Financial and Strategic SWOT Analysis Review

      Owens & Minor Inc (OMI) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses ... Read More

    • Bayer AG (BAYN) - Financial and Strategic SWOT Analysis Review

      Bayer AG (BAYN) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the ... Read More

    • Ligand Pharmaceuticals Inc (LGND) - Financial and Strategic SWOT Analysis Review

      Ligand Pharmaceuticals Inc (LGND) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and ... Read More

    • F. Hoffmann-La Roche Ltd (ROG) - Financial and Strategic SWOT Analysis Review

      F. Hoffmann-La Roche Ltd (ROG) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea ... Read More

    • Sangamo Therapeutics Inc (SGMO) - Financial and Strategic SWOT Analysis Review

      Sangamo Therapeutics Inc (SGMO) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we ... Read More

    • Exelixis Inc (EXEL) - Financial and Strategic SWOT Analysis Review

      Exelixis Inc (EXEL) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and ... Read More

    • Hepatitis B Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033

      Hepatitis B Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 Summary Hepatitis B Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 is built to visualize quantitative and qualitative market trends within In Vitro Diagnostics the ... Read More

    • Bio-Rad Laboratories Inc (BIO) - Product Pipeline Analysis, 2024 Update

      Bio-Rad Laboratories Inc (BIO) - Product Pipeline Analysis, 2024 Update Summary Bio-Rad Laboratories Inc (Bio-Rad) manufactures and distributes life science research and clinical diagnostics products. The company's product portfolio includes antibodies, autoimmune testing kits, blood typing and anti ... Read More

    • Clinical Trials: Adoptive Cell Therapy

      Clinical Trials: Adoptive Cell Therapy Summary This report provides an overview of Adoptive Cell Therapy clinical trials. As the number of Adoptive Cell Therapy clinical trials continues to increase, a deeper understanding of these trials, such as sponsor type, therapy areas, location, and phase, ar ... Read More

    • Thematic Intelligence: The State of the Biopharmaceutical Industry 2024 Edition (Mid-Year Update)

      Thematic Intelligence: The State of the Biopharmaceutical Industry 2024 Edition (Mid-Year Update) Summary Although the pharmaceutical industry is often labeled as a recession-resistant, it is not immune to future challenges. Ongoing issues such as constraints on drug pricing and reimbursement (P&R ... Read More

    • Insulin Pumps Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

      Insulin Pumps Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Insulin Pumps Pipeline Report including Stages of Development, Segments, Region and Countries, Regulato ... Read More

    • Stone Management Disposables Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033

      Stone Management Disposables Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 Summary Stone Management Disposables Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative and qualitative m ... Read More

13 14 15 16 17 18 19 20 21 22

Cookie Settings